BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 36718026)

  • 1. Prolactin in headache and migraine: A systematic review of clinical studies.
    Al-Karagholi MA; Kalatharan V; Ghanizada H; Gram C; Dussor G; Ashina M
    Cephalalgia; 2023 Feb; 43(2):3331024221136286. PubMed ID: 36718026
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prolactin in headache and migraine: A systematic review of preclinical studies.
    Al-Karagholi MA; Kalatharan V; Ghanizada H; Dussor G; Ashina M
    Headache; 2023 May; 63(5):577-584. PubMed ID: 36752584
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Relationship between high prolactin levels and migraine attacks in patients with microprolactinoma.
    Bosco D; Belfiore A; Fava A; De Rose M; Plastino M; Ceccotti C; Mungari P; Iannacchero R; Lavano A
    J Headache Pain; 2008 Apr; 9(2):103-7. PubMed ID: 18256782
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hyperprolactinemia and prolactinoma.
    Romijn JA
    Handb Clin Neurol; 2014; 124():185-95. PubMed ID: 25248588
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evidence for hyperprolactinemia in migraineurs: a systematic review and meta-analysis.
    Noori-Zadeh A; Karamkhani M; Seidkhani-Nahal A; Khosravi A; Darabi S
    Neurol Sci; 2020 Jan; 41(1):91-99. PubMed ID: 31444732
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Headache, hyperprolactinemia, and prolactinomas.
    Strebel PM; Zacur HA; Gold EB
    Obstet Gynecol; 1986 Aug; 68(2):195-9. PubMed ID: 3737035
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prolactinoma-associated headache and dopamine agonist treatment.
    Kallestrup MM; Kasch H; Østerby T; Nielsen E; Jensen TS; Jørgensen JO
    Cephalalgia; 2014 Jun; 34(7):493-502. PubMed ID: 24351278
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pituitary prolactin-secreting tumor formation: recent developments.
    Xu RK; Wu XM; Di AK; Xu JN; Pang CS; Pang SF
    Biol Signals Recept; 2000; 9(1):1-20. PubMed ID: 10686432
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Macroprolactinemia in patients with prolactinomas: prevalence and clinical significance.
    Elenkova A; Genov N; Abadzhieva Z; Kirilov G; Vasilev V; Kalinov K; Zacharieva S
    Exp Clin Endocrinol Diabetes; 2013 Apr; 121(4):201-5. PubMed ID: 23595795
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The metabolic role of prolactin: systematic review, meta-analysis and preclinical considerations.
    Corona G; Rastrelli G; Comeglio P; Guaraldi F; Mazzatenta D; Sforza A; Vignozzi L; Maggi M
    Expert Rev Endocrinol Metab; 2022 Nov; 17(6):533-545. PubMed ID: 36447418
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Macroprolactinemia in women with hyperprolactinemia: a 10-year follow-up.
    Radavelli-Bagatini S; Lhullier FL; Mallmann ES; Spritzer PM
    Neuro Endocrinol Lett; 2013; 34(3):207-11. PubMed ID: 23685418
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Hyperprolactinemia unrelated to prolactinoma].
    Krysiak R; Okopień B
    Wiad Lek; 2014; 67(2 Pt 1):101-11. PubMed ID: 25764785
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Osteoporotic fractures in patients with untreated hyperprolactinemia vs. those taking dopamine agonists: A systematic review and meta-analysis.
    D'Sylva C; Khan T; Van Uum S; Fraser LA
    Neuro Endocrinol Lett; 2015; 36(8):745-9. PubMed ID: 26921574
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Speed of response to dopaminergic agents in prolactinomas.
    Hage C; Salvatori R
    Endocrine; 2022 Mar; 75(3):883-888. PubMed ID: 34846682
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pituitary response profile following metoclopramide administration in women with different forms of hyperprolactinemia.
    Espinós JJ; Vanrell C; Gich I; Urgell E; Calaf J
    Gynecol Endocrinol; 2017 Feb; 33(2):148-151. PubMed ID: 27841032
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Migraine Progression: A Systematic Review.
    Buse DC; Greisman JD; Baigi K; Lipton RB
    Headache; 2019 Mar; 59(3):306-338. PubMed ID: 30589090
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum Prolactin Level to Tumor Size Ratio as a Potential Parameter for Preoperative Differentiation of Prolactinomas from Hyperprolactinemia-Causing Non-functional Pituitary Adenomas.
    Kim JH; Hur KY; Hong SD; Choi JW; Seol HJ; Nam DH; Lee JI; Kong DS
    World Neurosurg; 2022 Mar; 159():e488-e496. PubMed ID: 34958988
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Resolution of migraine following bromocriptine treatment of a prolactinoma (pituitary microadenoma).
    Hartman N; Voron SC; Hershman JM
    Headache; 1995; 35(7):430-1. PubMed ID: 7672963
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Importance of macroprolactinemia in hyperprolactinemia.
    Kasum M; Pavičić-Baldani D; Stanić P; Orešković S; Sarić JM; Blajić J; Juras J
    Eur J Obstet Gynecol Reprod Biol; 2014 Dec; 183():28-32. PubMed ID: 25461348
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increased body weight associated with prolactin secreting pituitary adenomas: weight loss with normalization of prolactin levels.
    Greenman Y; Tordjman K; Stern N
    Clin Endocrinol (Oxf); 1998 May; 48(5):547-53. PubMed ID: 9666865
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.